In the present study, we aimed to investigate the changes in serum ACE2 levels, Ang-(1–7) levels, and their association with kidney and vascular function after using olmesartan, compared with a conventional antihypertensive drug (amlodipine) in patients with T2D and hypertension. This evidence concerns the gene ACE2 and Hypertension.